Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Publicis Groupe’s The Kaplan Thaler Group has landed creative duties on Pfizer’s Lipitor, according to company representative Alison Lehanski.
Estimated billings are $60-80 million.
The other finalists were WPP Group’s JWT and independent mcgarrybowen. Those shops, along with Kaplan Thaler, pitched from their offices in New York.
Kaplan Thaler is already a client roster shop, handling Pfizer’s Celebrex brand.
The Lipitor selection came after a seven-month review in which the incumbent, Omnicom Group’s Merkley + Partners, defended, but was cut in September.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in